This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Michigan. Active years: 2014-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2015
Title: Abraham F L Van Der Spek: Innovator in Dendrimer Technology
Introduction
Abraham F L Van Der Spek is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of therapeutic and diagnostic dendrimers. With a total of 2 patents, his work focuses on innovative solutions for medical applications.
Latest Patents
His latest patents revolve around dendrimer conjugates. The present invention relates to novel therapeutic and diagnostic dendrimers. In particular, it is directed to dendrimer-linker conjugates, methods of synthesizing the same, and compositions comprising the conjugates. These systems and methods utilize the conjugates in diagnostic and therapeutic settings, such as the delivery of therapeutics, imaging, and targeting agents. This includes applications in disease diagnosis and therapy, particularly in cancer and pain therapy. The dendrimer-linker conjugates may also comprise components for targeting, imaging, sensing, and providing therapeutic or diagnostic materials, as well as monitoring responses to therapy.
Career Highlights
Abraham F L Van Der Spek is affiliated with the University of Michigan, where he continues to advance his research and innovations. His work has garnered attention for its potential impact on medical science and patient care.
Collaborations
He has collaborated with notable colleagues, including James R Baker, Jr and Xue-min Cheng, contributing to a rich environment of innovation and research.
Conclusion
Abraham F L Van Der Spek stands out as an influential inventor in the realm of dendrimer technology, with his patents paving the way for advancements in therapeutic and diagnostic applications. His contributions are poised to make a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
